Table 1. Patients characteristics.
| Patient | Sex | Age at SIRT | Age LT | Etiology | BCLC | PVTT | MELD pre Y90 | MELD LT | Afeto pre Y | Afeto OLT | Interval SIRT-LT | Survival from OLT (months) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | M | 62 | 64 | HCV | C | Vp3 | 10 | 11 | 30,000.0 | 110.00 | 29.90 | 76.3 |
| 2 | M | 41 | 43 | HCV | C | Vp1 | 10 | 13 | 5.0 | 7.00 | 14.40 | 66.2 |
| 3 | M | 66 | 66 | HCV | C | Vp1 | 13 | 24 | 20.0 | 3.72 | 5.80 | 8.1 |
| 4 | M | 57 | 58 | HCV + alcohol | C | Vp1 | 7 | 9 | 4.6 | 6.30 | 13.33 | 6.0 |
SIRT, selective internal radiation therapy; LT, liver transplantation; HCV, hepatitis C virus; BCLC, Barcelona clinic liver cancer; PVTT, portal vein tumor thrombosis; OLT, orthotopic liver transplantation.